Reborn Medical

Reborn is developing a portable and safe brain scanner based on ultrasound technology. Reborn's high-resolution 3D imaging system, comparable to a CT scan, can be used anytime, anywhere. With a primary focus on the ICU market, Reborn aims to address challenges associated with extended waiting times, transportation risks, and potential radiation effects. The implementation of Reborn's scanner is anticipated to yield significant reductions in hospitalization days, infections, and treatment delays, thereby resulting in annual cost savings amounting to billions of dollars for US hospitals.

Reborn Medical has raised $2.02M in total funding across 2 rounds. The company is currently at the Seed stage. Key investors include ICI Fund.

Reborn Medical was founded in 2021 by Shir Kashi (Founder & CEO).

Reborn Medical operates in Health Tech & Life Sciences, Medical Devices, Diagnostics Devices, with core technologies in Simulation & Imaging, Ultrasound, Artificial Intelligence. Target customers: Healthcare & Life Sciences, Healthcare, Providers.

Reborn Medical is based in Ha-Namal St 29, Haifa, Israel.